Connection

LYNN YEOMAN to Humans

This is a "connection" page, showing publications LYNN YEOMAN has written about Humans.
Connection Strength

0.056
  1. US Pharmacopeia Council of Experts 2005-2010: work plans, new revision approaches, and other enhancements. AAPS J. 2006; 8(4):E661-4.
    View in: PubMed
    Score: 0.007
  2. Transferrin and insulin enhance human colon tumor cell growth by differentiation class specific mechanisms. Oncol Res. 1996; 8(7-8):273-9.
    View in: PubMed
    Score: 0.004
  3. Growth control in a human colon carcinoma cell line mediated by cell-associated transforming growth factor-alpha (TGF alpha). Exp Cell Res. 1993 May; 206(1):49-57.
    View in: PubMed
    Score: 0.003
  4. Transforming growth factor-alpha production and autoinduction in a colorectal carcinoma cell line (DiFi) with an amplified epidermal growth factor receptor gene. Cancer Res. 1993 Apr 01; 53(7):1630-6.
    View in: PubMed
    Score: 0.003
  5. An autocrine model for cell- and matrix-associated fibroblast growth factor. Oncol Res. 1993; 5(12):489-99.
    View in: PubMed
    Score: 0.003
  6. Inhibition of colon tumor cell growth by 8-chloro-cAMP is dependent upon its conversion to 8-chloro-adenosine. Anticancer Drugs. 1992 Oct; 3(5):485-91.
    View in: PubMed
    Score: 0.003
  7. Sensitivity of nuclear c-myc levels and induction to differentiation-inducing agents in human colon tumor cell lines. Cancer Lett. 1992 Feb 29; 62(2):95-105.
    View in: PubMed
    Score: 0.003
  8. Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell lines. J Cell Physiol. 1992 Feb; 150(2):320-6.
    View in: PubMed
    Score: 0.003
  9. Lipofectin enhances cellular uptake of antisense DNA while inhibiting tumor cell growth. Antisense Res Dev. 1992; 2(1):51-9.
    View in: PubMed
    Score: 0.003
  10. Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient. Cancer Res. 1991 Mar 01; 51(5):1452-9.
    View in: PubMed
    Score: 0.003
  11. Characterization of two monoclonal antibodies that recognize high molecular weight colon antigens. Cancer Lett. 1989 Feb; 44(2):127-36.
    View in: PubMed
    Score: 0.002
  12. Different epidermal growth factor growth responses and receptor levels in human colon carcinoma cell lines. Cancer Lett. 1988 Dec 01; 43(1-2):139-43.
    View in: PubMed
    Score: 0.002
  13. Characterization and reactivity of a monoclonal antibody that recognizes a 76 kilodalton human colon tumor antigen. Cancer Lett. 1988 Mar; 39(2):161-77.
    View in: PubMed
    Score: 0.002
  14. Variation in cytosolic protein expression between human colon tumors that differ with regard to differentiation class. Clin Chem. 1988 Jan; 34(1):71-5.
    View in: PubMed
    Score: 0.002
  15. Equivalence studies for complex active ingredients and dosage forms. AAPS J. 2005 Nov 17; 7(4):E786-812.
    View in: PubMed
    Score: 0.002
  16. Occurrence of cytosolic protein and phosphoprotein changes in human colon tumor cells with the development of resistance to mitomycin C. Cancer Res. 1985 Sep; 45(9):4422-7.
    View in: PubMed
    Score: 0.002
  17. Rate of growth and extent of differentiation reflected by cytoplasmic proteins and antigens of human colon tumor cell lines. Cancer Res. 1984 Mar; 44(3):1200-5.
    View in: PubMed
    Score: 0.002
  18. Identification of cytosolic antigens from GW-39 adenocarcinoma cells by crossed immunoelectrophoresis and immunofluorescence. Immunol Commun. 1983; 12(3):315-29.
    View in: PubMed
    Score: 0.001
  19. Isolation and partial characterization of a 700 kilodalton human colon carcinoma associated antigen. Cancer Biochem Biophys. 1983; 6(4):249-59.
    View in: PubMed
    Score: 0.001
  20. Comparison of immunoelectrophoretic techniques for the analysis of cytosol antigens. J Immunol Methods. 1981; 43(3):301-11.
    View in: PubMed
    Score: 0.001
  21. Two-dimensional polyacrylamide gel analysis on nuclear proteins from human tumor cell lines. Cancer. 1978 Aug; 42(2):474-82.
    View in: PubMed
    Score: 0.001
  22. Differences in chromatin proteins of resting and growing human lymphocytes. Exp Cell Res. 1976 Jun; 100(1):47-55.
    View in: PubMed
    Score: 0.001
  23. Down-modulation of epidermal growth factor receptor accompanies TNF-induced differentiation of the DiFi human adenocarcinoma cell line toward a goblet-like phenotype. J Cell Physiol. 1993 Nov; 157(2):253-62.
    View in: PubMed
    Score: 0.001
  24. Isolation and composition of nuclei and nucleoli. Acta Endocrinol Suppl (Copenh). 1972; 168:35-66.
    View in: PubMed
    Score: 0.001
  25. Overcoming mitomycin C resistance with semisynthetic derivatives. Prog Clin Biol Res. 1986; 223:63-79.
    View in: PubMed
    Score: 0.000
  26. Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000; pI, 8.5) rich in NG,NG-dimethylarginine. J Biol Chem. 1985 Nov 15; 260(26):14304-10.
    View in: PubMed
    Score: 0.000
  27. Identification of endogenous inhibitory growth factors from a human colon carcinoma cell line. Cancer Res. 1985 May; 45(5):2248-54.
    View in: PubMed
    Score: 0.000
  28. Identification of a tumor inhibitory factor in rat ascites fluid. Biochem Biophys Res Commun. 1984 Feb 29; 119(1):76-82.
    View in: PubMed
    Score: 0.000
  29. Heterogeneity of human colon carcinoma. Cancer Metastasis Rev. 1984; 3(3):177-91.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.